Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure-Reference-Cited by-同舟云学术

Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure

Published:2018-08 Issue:2 Volume:68 Page:400-407
ISSN:0741-5214
Container-title:Journal of Vascular Surgery
language:en
Short-container-title:Journal of Vascular Surgery

Author:

Dieplinger Benjamin,Egger Margot,Luft Christian,Hinterreiter Franz,Pernerstorfer Thomas,Haltmayer Meinhard,Mueller Thomas

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference18 articles.

1. Pharmacokinetics of low-molecular-weight heparin and unfractionated heparin during elective aortobifemoral bypass grafting;Kroneman;J Vasc Surg,1991

2. Ischaemia and reperfusion during open abdominal aortic aneurysm surgery induce extensive thrombin generation and activity;Holmberg;Eur J Vasc Endovasc Surg,1999

3. Coagulation, fibrinolysis, and platelet activation in patients undergoing open and endovascular repair of abdominal aortic aneurysm;Davies;J Vasc Surg,2011

4. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Hirsh;Chest,2004

5. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II);Norgren;Eur J Vasc Endovasc Surg,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran;JA Clinical Reports;2024-09-04

2. The Risk for Excessive Anticoagulation With Activated Clotting Time-Guided Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement;Structural Heart;2024-09

3. Comparison of Blood Concentration and Weight-Based Heparin and Protamine Dosing Strategies for Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis;Cureus;2024-02-13

4. Unfractionated heparin and the activated clotting time in non-cardiac arterial procedures;The Journal of Cardiovascular Surgery;2023-10

5. Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure;Diagnostics;2023-04-20